Home / News & Events
News Releases
GlycoNet releases its 2022-2023 Corporate Report
The report encapsulates a comprehensive overview of the network's achievements, breakthroughs, and collaborations in the field of glycomics throughout the past year. Within the report,
Senator Paula Simons gets the sweet scoop on GlycoNet and glycomics
Senator Paula Simons recently toured GlycoNet at the University of Alberta, exploring the realm of glycomics. The visit highlighted GlycoNet's pivotal role in advancing glycomics
GlycoNet researchers develop ‘ice inhibitors’ to protect cells during cryopreservation
New compounds could open more opportunities for vital medical treatments, organ and tissue transplants, and reproductive medicine.
More stories
- All
- Awards
- Community
- Network Profile
- Press Release
- Research Highlight
Decoding sugars: Harnessing glycomics to fight infectious diseases
GlycoNet scientists are expanding our knowledge of sugars to engineer new health solutions.
Sweet science in the spotlight at the 2023 Canadian Glycomics Symposium
Over 150 top researchers, industry experts, and emerging talent in glycomics recently gathered in Edmonton, Alberta to discuss advancements and the latest trends in glycomics.
Empowering scientists to drive One Health innovation globally
GlycoNet and its Integrated Services advance glycomics research and innovation towards new solutions.
GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation
Five glycomics projects have been awarded funding to develop new tools, diagnostics and therapeutics to improve health for Canadians.
A Tour of the GlycoNet facilities with the Honourable Randy Boissonnault
A significant gathering of researchers, industry experts, and rising stars in glycomics recently took place in Edmonton, Alberta with the Honourable Randy Boissonnault, focusing on
Cutting-edge research goes beyond skin deep
Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at
PlantForm and UBC researcher receive GlycoNet funds to develop novel treatment for Type-2 diabetes
PlantForm Corporation has teamed up with a University of British Columbia research group led by Dr. Joerg Bohlmann to develop a novel plant-based treatment option
Glycoengineering provides insight into new cancer immunotherapies
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Redefining compatibility in organ transplantation
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 780-492-6204
Fax: 780-492-4147
Subscribe to GlycoNet’s Newsletter
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.
English 
French